Winter 2009 [pdf] - University of Kentucky - College of Pharmacy

UK College of Pharmacy Welcomes Three
New Faculty Members
Heidi Mansour, Ph.D., Younsoo Bae, Ph.D., and Wooin Lee, Ph.D., have joined the College as assistant
professors in the Division of Drug Development.
Dr. Mansour’s research
focuses on the application of
interfacial phenomena and
biocolloidal chemistry in the
design of advanced drug
delivery self-assembly systems
and development of pulmonary
inhalation aerosols for targeted
lung drug delivery (pulmonary
disease treatment) and for novel
needle-free vaccine inhalation
aerosol delivery (pulmonary
disease prevention) as
multifunctional microparticles and nanoparticles.
She earned a B.S. in pharmacy (1996) and a Ph.D. in
pharmaceutical sciences (2003) from the University of
Wisconsin at Madison. Dr. Mansour recently was honored
during the 2007 American Association of Pharmaceutical
Scientists annual meeting in San Diego, receiving the PhRMA
Postdoctoral Fellow Award in Pharmaceutics and the AAPS
Postdoctoral Fellow Award for research excellence.
Prior to her appointment at UK, she was an Instructor (both
in the Graduate and Pharm.D. Programs) and a postdoctoral
fellow at the University of North Carolina at Chapel Hill School
of Pharmacy, in the Division of Molecular Pharmaceutics,
receiving the 2007 UNC-Chapel Hill Postdoctoral Award for
Research Excellence from the Office of the Vice Chancellor.
Staff Changes at UK COP
Stephanie Wurth joined the College in
November as Recruiter and Pre-Pharmacy
Advisor. She previously served as the
International Student Advisor in the
UK Office of International Affairs. She
received a B.S. in Integrated Strategic
Communications from UK and is currently
completing a M.S. in Community and
Leadership Development.
Mary Morse joined the College in
November as administrative assistant
to Dean Kenneth Roberts. She
previously served as executive secretary
to the president of the Council on
Postsecondary Education.
Dr. Bae’s research is focused on
the development of intelligent
polymer nanovehicles for
controlled combination delivery
of potential bioactives to targeted
lesions. Bioactives may include
anticancer drugs, proteins, and
nucleotide drugs while targeted
legions are tumor vasculatures,
hormone-sensitive human
cancers (breast, ovary, uterine
and prostate), and drug-resistant
cancers. Heat shock proteins and
proteasomes are the major molecular targets of interest for the
combination therapy using intelligent polymer nanovehicles,
along with conventional chemotherapy.
He received a B.E. in textile/polymer engineering (1999)
from Hanyang University, South Korea, and a master’s degree
(2002) and Ph.D. in materials science (2005) both from the
University of Tokyo, Japan. Prior to his post at UK, Dr. Bae
served as a postdoctoral researcher and research associate at
the University of Tokyo, School of Engineering and School of
Medicine, and at the University of Wisconsin-Madison School
of Pharmacy.
Dr. Lee’s research focuses on the
genetic and molecular bases for
interindividual variations in drug
metabolism and transport and the
role of drug transporters in cancer
development and progression.
She also has been also developing
translational research programs
incorporating pharmacokinetic,
pharmacogenomic and other
correlative studies into early
clinical trials.
Dr. Lee received her doctoral
degree in pharmaceutical sciences (2002) at the State
University of New York at Buffalo and a master’s degree
(1995) in pharmacology at Seoul National University. She also
received a bachelor’s degree (1993) in pharmacy from Seoul
National University.
Prior to her appointment at UK, she completed
a postdoctoral fellowship in the Division of Clinical
Pharmacology at Vanderbilt University and worked as a
research assistant professor in the Division of Hematology and
Oncology at Vanderbilt University.
18 Focus on Pharmacy